๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer

โœ Scribed by Joseph C. Allegra; Marc E. Lippman; E.Brad Thompson; Richard Simon; Audrey Barlock; Linda Green; Karen K. Huff; Hoan M.Y.T. Do; Susan C. Aitken; Robert Warren

Book ID
113146620
Publisher
Elsevier Science
Year
1980
Weight
938 KB
Volume
16
Category
Article
ISSN
0014-2964

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Influence of estrogen receptor status on
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy
โœ Dr. Bellarmine V. Lawrence; Allan Lipton; Harold A. Harvey; Richard J. Santen; S ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 563 KB

Aminoglutethimide (AG) is an effective chemical ablative form of therapy for metastatic breast cancer in postmenopausal women. Estrogen receptor (ER) status in breast cancer is useful in predicting the response to the hormonal treatments. Of 134 postmenopausal metastatic breast cancer patients treat

Estrogen and progesterone receptors in t
Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy
โœ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 302 KB ๐Ÿ‘ 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to